期刊文献+

无抽搐电休克疗法治疗难治性抑郁疗效观察 被引量:6

Study on experience in treatment of refractory depression with no twitch electric shock therapy
下载PDF
导出
摘要 目的探讨难治性抑郁症(TRD)的治疗方法,为临床治疗TRD提供新的治疗方案。方法选取2009年4月至2010年5月接收的60例TRD病例,将其随机分为研究组和对照组,各30例,研究组采用无抽搐电休克疗法治疗TRD,对照组采用常规抗抑郁药物治疗TRD,对比分析两组治疗TRD的治疗效果以及不良反应。结果研究组治疗后第1、2、4周的HAMD平均减分率分别25.1%、34.9%、64.9%,而对照组治疗后第1、2、4周的HAMD平均减分率分别为4.9%、8.5%、16.8%。研究组的HAMD平均减分率明显高于对照组的HAMD平均减分率。治疗结束后1周,研究组的总有效率为63.33%;对照组的总有效率为30.00%,研究组总有效率明显高于对照组。结论相比于常规药物治疗,无抽搐电休克疗法治疗TRD具有见效快、疗效好、不良反应少以及患者依从性好等诸多优点,是临床上治疗TRD安全、快速、有效的方法。 Objective To explore the treatment of refractory depression,and to provide new approach for clinical treatment of refractory depression.Methods Sixty patients with refractory depression in this hospital during April 2009 to May 2010 were randomly divided into study group and control group,each group with 30 cases.Patients in study group received no twitch electric shock therapy for treatment of their depression,and patients in control group were given with conventional therapy of antidepressant medication for treatment of refractory depression,and the effect of treatment and adverse reactions were compared between these 2 groups.Results After treatment for 1,2 and 4 weeks,HAMD average minus points in patients of study group were 25.1%,34.9% and 64.9% respectively,and the HAMD average minus points in patients of control group after treatment for 1,2 and 4 weeks were 4.9%,8.5%,16.8% respectively.The average deduction rate of HAMD in patients of study group was significantly higher than that of patients in control group.The total effective rate of patients in study group after treatment for 1 week was 63.33%,and the total effective rate of patients in control group was 30%,hence the total effective rate of patients in study group was significantly higher than that of patients in control group.Conclusion In comparison with conventional drugs,no twitch electric shock therapy in treatment of refractory depression has quicker and better efficacy and fewer side effects and many other advantages,and compliance of patients is good,hence it is a clinically safe,fast and effective method for treatment of refractory depression,and it is worthy to be clinical application.
作者 叶其群 田伟
出处 《临床和实验医学杂志》 2013年第3期197-198,共2页 Journal of Clinical and Experimental Medicine
关键词 难治性抑郁症 无抽搐电休克疗法 疗效 Refractory depression No twitch electric shock therapy Effect
  • 相关文献

参考文献8

二级参考文献76

共引文献50

同被引文献39

  • 1粟幼嵩,陈俊,李则挚,王勇,黄佳,方贻儒,王祖承.碳酸锂联合阿立哌唑治疗双相障碍抑郁发作的疗效和安全性[J].上海交通大学学报(医学版),2011,31(11):1536-1539. 被引量:24
  • 2陈圣霞,魏春香,朱凤玲.阿立哌唑治疗精神分裂症临床观察[J].临床精神医学杂志,2006,16(1):46-47. 被引量:50
  • 3易正辉,徐庆华,盛国红,吴晓波,吴国君.无抽搐电休克治疗难治性精神分裂症临床观察[J].临床精神医学杂志,2006,16(5):280-281. 被引量:36
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M].济南:山东科技出版社.2011,68-69.
  • 5Kadam NS, Patil RA, Gurav AN, et al. Duloxetine Hydrochloride- Induced Oral Liehenoid Reaction: A Case Report [ J 1. Med Princ Pratt. 2015:394-397.
  • 6Cooper C, Katona C, Lyketsos K, et al. A systematic review of treatments for refractory depression in older people [ J ]. Am J Psychiatry, 2011,168(7) :6814588.
  • 7Yoshimura R, Kishi T, Hori H, et al. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients withrefractory major depressive disorder[J]. Prog Neuropsychopharmacol Biol Psychiatry,2012;39(2) :355-357.
  • 8Ahmed Kamal M, Shaheer Malik, Ahmad Ali Shaik, et al. Lipase mediated resolution of 'y-azidoalcohols in aqueous and organic media: Synthesis of (R) - and (S) -fluoxetine and duloxetine[ J]. J Mol Catal B Enzym ,2009,58 ( 1/4 ) : 132-137.
  • 9Kumar N, Sangeetha D, Vaghela B, et al. Development and validation of a stability indicating RP-LC method for the estimation of process related impurities and degradation products of duloxetine hydroehloride and phthalic acid in duloxetine hydrochloride delayed release capsules [ J~. J Liq Chromatogr Relat Techno1,2012,35 (5/8) :867-881.
  • 10Borges NC, Barrientos-Astigarraga RE, Sverdloff CE, et al. A fast, sensitive and simple method for mirtazapine quantification in human plasma by HPLC-ESI-MS/MS. Application to a comparative bioavailability study [ J ]. Biomed Chromatogr, 2012, 26 (11): 1399-1407.

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部